Tuberculosis remains a global health problem, with an estimated 10.4 million cases and 1.8
million deaths resulting from the disease in 2015. The most lethal and disabling form of …

Background Tuberculosis (TB) is the second most common cause of death due to a single
infectious agent worldwide after COVID-19. Up to 15% of the cases are extrapulmonary, and …

Background Adjunctive glucocorticoids are widely used to treat human immunodeficiency
virus (HIV)–associated tuberculous meningitis despite limited data supporting their safety …

Tuberculous meningitis is a devastating brain infection that is caused by Mycobacterium
tuberculosis and is notoriously difficult to diagnose and treat. New technologies …

Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency
syndrome (HIV/AIDS) constitute the main burden of infectious disease in resource-limited …

Tuberculous meningitis is especially common in young children and people with untreated
HIV infection, and it kills or disables roughly half of everyone affected. Childhood disease …

Tuberculosis (TB) remains a leading cause of death globally. Dissemination of TB to the
brain results in the most severe form of extrapulmonary TB, tuberculous meningitis (TBM) …

The CDC/NIH/HIVMA Guidelines for Prevention and Treatment of Opportunistic Infections in
HIV-Infected Adults and Adolescents have been revised. Major areas of revision include …

Access to antiretroviral therapy (ART) is improving worldwide. Immune reconstitution
inflammatory syndrome (IRIS) is a common complication of ART initiation. In this review, we …

Despite significant reductions in morbidity and mortality secondary to availability of effective
combination anti‐retroviral therapy (cART), human immunodeficiency virus (HIV) infection …